Get the Stockscreener App
393.48
0.10%
+0.38
Pre-market:
393.48
Vertex Pharmaceuticals, Inc. Stock (VRTX) Forecast
The Vertex Pharmaceuticals, Inc. (VRTX) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $497.99, representing a +26.56% increase from the current price of $393.48. The highest analyst price target is $570.26, and the lowest is $425.72.
Based on our technical indicators, the current sentiment is bearish but VRTX could still hit $654.96 in 2025. This might not be a good time to consider opening new positions on VRTX, as trading bearish markets can be challenging and may result in losses.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VRTX Price Target
Average 497.99
(+26.56% Upside)
Vertex Pharmaceuticals, Inc. Stock (VRTX) Technical Analysis Forecast
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.51 | Neutral |
| STOCH(9,6) | 12.74 | Buy |
| STOCHRSI(14) | 2.961 | Buy |
| MACD(12,26) | -6.0479 | Sell |
| ADX(14) | 29.82 | Sell |
| William %R | -91.89 | Buy |
| CCI(14) | -103.59 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
398.79
Sell
|
398.64
Sell
|
| MA20 |
406.59
Sell
|
403.76
Sell
|
| MA50 |
414.21
Sell
|
409.44
Sell
|
| MA100 |
408.69
Sell
|
403.80
Sell
|
| MA200 |
381.88
Buy
|
384.29
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
Long-term VRTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Our analysts are offering long term price forecasts for Vertex Pharmaceuticals, Inc. In 2050, the median target price for VRTX is $2,886.57, with a high estimate of $2,887.48 and a low estimate of $2,484.62. The median estimate represents a +633.60% increase from the last price of $393.48. Below is our long term VRTX Price forecast table with detailed price target for each year.
| Year | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| 2024 | $511.73 | $402.41 | $512.46 | +30.05% |
| 2025 | $626.18 | $511.84 | $654.96 | +59.14% |
| 2026 | $625.92 | $573.70 | $648.78 | +59.07% |
| 2027 | $783.20 | $611.44 | $787.20 | +99.04% |
| 2028 | $886.62 | $765.57 | $901.29 | +125.33% |
| 2029 | $692.45 | $630.22 | $1,005.50 | +75.98% |
| 2030 | $862.53 | $692.90 | $892.71 | +119.21% |
| 2035 | $1,034.81 | $869.43 | $1,597.99 | +162.99% |
| 2040 | $1,159.42 | $1,108.64 | $2,190.49 | +194.66% |
| 2045 | $2,568.87 | $2,247.45 | $2,573.17 | +552.86% |
| 2050 | $2,886.57 | $2,484.62 | $2,887.48 | +633.60% |
Vertex Pharmaceuticals, Inc. Stock (VRTX) Year by Year Forecast
Vertex Pharmaceuticals, Inc. Stock (VRTX) Price Forecast for 2024
For Vertex Pharmaceuticals, Inc. Stock (VRTX) price forecast for 2024, the average price target for Vertex Pharmaceuticals, Inc. Stock is $457.43 with a high forecast of $512.46 and a low forecast of $402.41. The average VRTX price prediction of 2024 represents a +16.25% increase from the last price of $393.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $438.98 | $425.72 | $446.84 | +11.56% |
| June, 2024 | $437.05 | $431.81 | $445.19 | +11.07% |
| July, 2024 | $454.30 | $437.45 | $461.60 | +15.46% |
| August, 2024 | $448.93 | $446.06 | $458.01 | +14.09% |
| September, 2024 | $466.59 | $452.60 | $474.32 | +18.58% |
| October, 2024 | $458.52 | $456.60 | $471.60 | +16.53% |
| November, 2024 | $473.28 | $459.72 | $477.14 | +20.28% |
| December, 2024 | $511.73 | $472.96 | $512.46 | +30.05% |
Vertex Pharmaceuticals, Inc. Stock (VRTX) Price Forecast for 2025
Vertex Pharmaceuticals, Inc. Stock (VRTX) is expected to reach an average price of $583.40 in 2025, with a high prediction of $654.96 and a low estimate of $511.84. This indicates an +48.27% rise from the last recorded price of $393.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $526.54 | $511.84 | $533.36 | +33.82% |
| February, 2025 | $530.74 | $524.97 | $533.25 | +34.88% |
| March, 2025 | $556.65 | $530.96 | $563.17 | +41.47% |
| April, 2025 | $555.19 | $537.62 | $570.26 | +41.10% |
| May, 2025 | $564.33 | $523.20 | $567.26 | +43.42% |
| June, 2025 | $585.34 | $551.72 | $609.40 | +48.76% |
| July, 2025 | $624.16 | $583.34 | $634.50 | +58.62% |
| August, 2025 | $637.01 | $594.56 | $639.21 | +61.89% |
| September, 2025 | $644.29 | $627.05 | $654.64 | +63.74% |
| October, 2025 | $621.86 | $615.87 | $654.96 | +58.04% |
| November, 2025 | $625.88 | $620.44 | $642.83 | +59.06% |
| December, 2025 | $626.18 | $614.55 | $640.78 | +59.14% |
Vertex Pharmaceuticals, Inc. Stock (VRTX) Price Forecast for 2026
The 2026 price forecast for Vertex Pharmaceuticals, Inc. Stock (VRTX) stands at an average of $611.24. Projections range from a high of $648.78 to a low of $573.70, signifying an +55.34% increase from the previous price of $393.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $578.55 | $573.70 | $648.78 | +47.03% |
| February, 2026 | $601.71 | $573.96 | $601.72 | +52.92% |
| March, 2026 | $615.47 | $599.53 | $619.58 | +56.42% |
| April, 2026 | $623.40 | $605.72 | $627.64 | +58.43% |
| May, 2026 | $597.64 | $597.41 | $630.00 | +51.89% |
| June, 2026 | $611.27 | $596.44 | $616.96 | +55.35% |
| July, 2026 | $620.82 | $609.76 | $624.21 | +57.78% |
| August, 2026 | $620.87 | $614.11 | $626.41 | +57.79% |
| September, 2026 | $600.10 | $597.89 | $628.31 | +52.51% |
| October, 2026 | $615.21 | $598.77 | $619.09 | +56.35% |
| November, 2026 | $617.42 | $613.34 | $625.86 | +56.91% |
| December, 2026 | $625.92 | $613.10 | $630.42 | +59.07% |
Vertex Pharmaceuticals, Inc. Stock (VRTX) Price Forecast for 2027
For 2027, the average price target for Vertex Pharmaceuticals, Inc. Stock (VRTX) is $699.32, with a high forecast of $787.20 and a low forecast of $611.44. This indicates an +77.73% increase from the last price of $393.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $614.07 | $612.70 | $626.12 | +56.06% |
| February, 2027 | $621.00 | $611.44 | $625.36 | +57.82% |
| March, 2027 | $627.08 | $619.08 | $640.82 | +59.37% |
| April, 2027 | $662.84 | $630.15 | $666.62 | +68.46% |
| May, 2027 | $682.39 | $662.75 | $688.72 | +73.42% |
| June, 2027 | $693.00 | $677.20 | $712.84 | +76.12% |
| July, 2027 | $702.58 | $686.80 | $707.10 | +78.56% |
| August, 2027 | $736.08 | $698.09 | $737.06 | +87.07% |
| September, 2027 | $747.95 | $735.82 | $765.08 | +90.09% |
| October, 2027 | $753.27 | $710.15 | $753.71 | +91.44% |
| November, 2027 | $778.10 | $727.52 | $778.72 | +97.75% |
| December, 2027 | $783.20 | $762.58 | $787.20 | +99.04% |
Vertex Pharmaceuticals, Inc. Stock (VRTX) Price Forecast for 2028
Vertex Pharmaceuticals, Inc. Stock (VRTX) is estimated to achieve an average price of $833.43 in 2028, with a high projection of $901.29 and a low estimate of $765.57. This suggests an +111.81% rise from the preceding price of $393.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $795.40 | $765.57 | $802.31 | +102.15% |
| February, 2028 | $793.28 | $775.97 | $799.78 | +101.61% |
| March, 2028 | $801.21 | $781.24 | $810.24 | +103.62% |
| April, 2028 | $822.78 | $790.76 | $826.06 | +109.10% |
| May, 2028 | $833.19 | $802.02 | $839.53 | +111.75% |
| June, 2028 | $811.29 | $809.67 | $843.95 | +106.18% |
| July, 2028 | $849.06 | $807.20 | $851.28 | +115.78% |
| August, 2028 | $826.07 | $820.79 | $854.00 | +109.94% |
| September, 2028 | $824.46 | $820.10 | $833.62 | +109.53% |
| October, 2028 | $876.75 | $826.73 | $877.40 | +122.82% |
| November, 2028 | $895.44 | $862.06 | $901.29 | +127.57% |
| December, 2028 | $886.62 | $872.85 | $900.98 | +125.33% |
Vertex Pharmaceuticals, Inc. Stock (VRTX) Price Forecast for 2029
The 2029 price forecast for Vertex Pharmaceuticals, Inc. Stock (VRTX) is $817.86 on average, with a high prediction of $1,005.50 and a low estimate of $630.22. This represents an +107.85% increase from the previous price of $393.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $897.03 | $877.06 | $912.59 | +127.97% |
| February, 2029 | $916.00 | $899.07 | $928.25 | +132.79% |
| March, 2029 | $918.52 | $905.06 | $925.84 | +133.44% |
| April, 2029 | $924.00 | $912.90 | $933.06 | +134.83% |
| May, 2029 | $941.14 | $918.72 | $955.21 | +139.18% |
| June, 2029 | $957.73 | $934.24 | $971.50 | +143.40% |
| July, 2029 | $940.24 | $927.19 | $966.88 | +138.96% |
| August, 2029 | $646.53 | $630.22 | $1,005.50 | +64.31% |
| September, 2029 | $679.94 | $644.18 | $686.25 | +72.80% |
| October, 2029 | $688.21 | $676.41 | $691.54 | +74.90% |
| November, 2029 | $700.42 | $683.25 | $703.55 | +78.01% |
| December, 2029 | $692.45 | $687.76 | $713.02 | +75.98% |
Vertex Pharmaceuticals, Inc. Stock (VRTX) Price Forecast for 2030
Vertex Pharmaceuticals, Inc. Stock (VRTX) is expected to reach an average price of $792.80 in 2030, with a high forecast of $892.71 and a low forecast of $692.90. This signifies an +101.49% surge from the last price of $393.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $702.08 | $692.90 | $708.85 | +78.43% |
| February, 2030 | $717.01 | $700.27 | $717.29 | +82.22% |
| March, 2030 | $730.76 | $713.88 | $738.06 | +85.72% |
| April, 2030 | $743.15 | $726.12 | $746.18 | +88.87% |
| May, 2030 | $753.86 | $739.82 | $760.40 | +91.59% |
| June, 2030 | $750.61 | $746.28 | $763.69 | +90.76% |
| July, 2030 | $791.07 | $754.18 | $792.12 | +101.05% |
| August, 2030 | $814.63 | $790.91 | $815.36 | +107.03% |
| September, 2030 | $838.31 | $815.94 | $841.07 | +113.05% |
| October, 2030 | $856.31 | $838.34 | $860.58 | +117.62% |
| November, 2030 | $875.17 | $854.39 | $881.69 | +122.42% |
| December, 2030 | $862.53 | $849.81 | $892.71 | +119.21% |
0.80%
Cap:
|
Volume (24h):